Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years

Endocrine Journal

Volumn 59, Issue 7, 2012, Pages 539-545

  Ito, Yasuhiro ^a   Kihara, Minoru ^a   Takamura, Yuuki ^a   Kobayashi, Kaoru ^a   Miya, Akihiro ^a   Hirokawa, Mitsuyoshi ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

Age; Papillary thyroid carcinoma; Prognosis

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CHILD; CONTROLLED STUDY; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; ECTOPIC THYROID GLAND; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; RECURRENCE FREE SURVIVAL; SCHOOL CHILD; SEX DIFFERENCE; SURVIVAL RATE; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME;

ADOLESCENT; AGE OF ONSET; CARCINOMA; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODES; MALE; NEOPLASM METASTASIS; PROGNOSIS; RECURRENCE; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84865652107     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0086     Document Type: Article

References (40)

1. th ed. New York: Wiley-Blackwell.
2. Cady B, Rosai R (1988) An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery 104: 947-953.
3. Hay ID, Bergstrahl EJ, Goellner JR, Ebersold JR, Grant CS (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114: 1050-1058.
4. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A (2004) A novel classification system for patients with PTC: addition of the new variable of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135: 139-148.
5. Ito Y, Kudo T, Kobayashi K, Miya A, Ichihara K, Miyauchi A (2012) Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph node, lung, and bone: analysis of 5,768 patients with average. World J Surg Jan 20 [Epub ahead of print].
6. Nikiforov Y, Grepp DR, Fagin JA (1996) Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis. J Clin Endocrinol Metab 81: 9-14.
7. Pacini F, Vorontsova T, Milinaro E, Shavrova E, Agate L, Kuchinskaya E, Elisei R, Demidchik EP, Phnchera A (1999) Thyroid consequences of the Chernobyl nuclear accident. Acta Paediastr Suppl 88: 23-27.
8. Tronko MD, Bogdanova TI, Komissarenko IV (1999) Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: statistical data and clinicopathologic characteristics. Cancer 86: 149-156.
9. Tronko M, Bogdanova T, Voskoboynyk L, Zumadzhy L, Shpak V, Gulak L (2010) Radiation induced thyroid cancer: fundamental and applied aspects. Exp Oncol 32: 200-204.
10. Taylor AJ, Croft AP, Palace AM, Winter DL, Reulen RC, Stiller CA, Stevens MC, Hawkins MM (2009) Risk of thyroid cancer in survivors of childhood cancer: results from Britis Childhood Cancer Survivor Study. Int J Cancer 125: 2400-2405.
11. Zimmerman D, hay ID, Gough IR, Goellner JR, Ryan JJ, Grant CS, McConahey WM (1988) Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 104: 1157-1166.
12. Ceccarelli C, Pacini F, Lippi F, Elisei R, Agranini M, Miccoli P, Pinchera A (1988) Thyroid cancer in children and adolescents. Surgery 104: 1143-1148.
13. Borson-Chazot F, Causeret S, Lifante JC, Augros M, Berger N, Peix JL (2004) Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer. World J Surg 28: 1088-1092.
14. Hod N, Hagag P, Baumer M, Sandbank J, Home T (2005) Differentiated thyroid carcinoma in children and young adults: evaluation of response to treatment. Clin Nucl Med 30: 387-390.
15. Palmer BA, Zarroug AE, Poley RN, Kollars JP, Moir CB (2005) Papillary thyroid carcinoma in children: risk factors and complications of disease recurrence. J Pediastr Surg 40: 1284-1288.
16. MIccoli P, Minuto MN, Upolini C, Panicucci E, Massi M, Berti P, Basolo F (2008) Papillary thyroid cancer: pathological parameters as prognostic factors in different classes of age. Otolaryngol Head Neck Surg 138: 200-203.
17. Vriens MR, Moses W, Weng J, Peng M, Griffin A, Bleyer A, Pollock BH, Indelicato DJ, Hwang J, Kebebew E (2011) Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer 117: 259-267.
18. Pependieck P, Bruneiro-Papendieck L, Venara M, Acha O, Magio S, Bergada I, Cheisa A (2011) Differentiated thyroid carcinoma: presentation and follow-up in children and adolescents. J Pediatr Endocrinol Metab 24: 743-748.
19. Huang CH, Chao TC, Hseuh C, Lin KJ, Ho TY, Lin SF, Lin JD (2012) Therapeutic lutcome and prognosis in young patients with papillary and follicular thyroid cancer. Pediastr Surg Int Jan 25 [Epub ahead of print].
20. Mazzaferri EL, Kloos RT (2001) Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86: 1447-1463.
21. Wada N, Sugino K, Mimura T, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Nakayama H, Hirakawa S, Yukawa N, Rino Y, Masuda M, Ito K (2009) Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation. Ann Surg Oncol 16: 3442-3449.
22. Enomoto Y, Enomoto K, Uchino S, Shibuya H, Watanabe S, Noguchi S (2012) Clinical features, treatment, and long-term outcome of papillary thyroid cancer in children and adolescents without radiation exposure. World J Surg in press.
23. Sobrinho-Simoes M, Carcangiu ML, Albores-Saavedra J (2004) Poorly differentiated carcinoma. In DeLeillis RA, Lloyd RV, Heitz PU editors, Pathology and genetics of tumous of endocrine organs, Lyon, IARC Press, 73-76.
24. Uruno T, Miyauchi A, Shimizu K, Tomoda C, Tokamura Y, Ito Y, Miya A, Kobayashi K, Matsuzuka F, Amino N, Kuma K (2005) Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg 29: 483-485.
25. Ito Y, Ichihara K, Masuoka H, Fukushima M, Inoue H, Kihara M, Tomoda C, Higashiyama T, Takamura Y, Kobayashi K, Miya A, Miyauchi A (2010) Establishment of an intraoperative staging system (iStage) by improving UICC TNM classification system for papillary thyroid carcinoma. World J Surg 34: 2570-2580.
26. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30: 780-786.
27. Kumagai A, Namba H, Saenko VA, Ashizawa K, Ohturu A, Ito M, Ishikawa N, Sugino K, Ito K, Jeremiah S, Thomas GA, Bogdanova TI, Tronko MD, Nagayasu T, Shitbata Y, Yamashita S (2004) Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas. J Clin Endocrinol Metab 89:4280-4284.
28. Fenton CL, Lukes Y, Nicholson D, Dinauer CA, Francis GL, Tuttle RM (2000) The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metab 85: 1170-1175.
29. Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carlson KA, Vaskko V, Larin A, Tallini G, Tolaney S, Holt EH, HUi P, Umbricht CB, Basaria S, Ewertz M, Tufano AP, Califano JA, Ringel MD, Zeiger MA, Sidransky D, Ladenson PW (2005) BRAF mutation predicts poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 90: 6373-6379.
30. Risco-Eizaguirre G, Gutierrez-Martinez P, Garcia-Cabezas MA, Nistal M, Santisteban P (2006) The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane. Endocr Relat Cancer 13: 257-269.
31. Ito Y, Yoshida H, Maruo R, Morita S, Takano T, Hirokawa M, Yabuta T, Fukushima M, Inoue H, Tomoda C, Kihara M, Uruno T, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A (2009) BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with highrisk clinicopathological features and disease-free survival of patients. Endocr J 56: 89-97.
32. Bongarone I, Vigneri P, Mariani I, Collini P, Pilotti S, Pierotti MA (1998) RET/NTRK1 rearrangement in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features. Clin Cancer Res 4: 223-228.
33. Delivincourt C, Patey M, Flament JB, Suarez HG, Larbre H, Jardillier JC, Delisle MJ (1996) Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Andrenne region. Clin Biochem 29: 267-271.
34. Sugg SL, Ezzat S, Zheng L, Freeman JL, Rosen IB, Asa SL (1999) Oncogene profile of papillary thyroid carcinoma. Surgery 125: 46-52.
35. Mayr B, Brabant G, Goretzki P, Ruschoff J, Dietmaier W, Dralle H (1997) ret/PTC-1, -2, and -3 oncogene rearrangement in human thyroid carcinomas: implications for metastatic potential? J Clin Endocrinol Metab 82: 1306-1307.
36. Kuo SF, Chao TC, Hsueh C, Chuang WY, Yang CH, Lin JD (2008) Prognosis and risk stratification in young papillary thyroid carcinoma patients. Endocr J 55: 269-275.
37. Fassina AS, Rupolo M, Pelizzo MR, Casara D (1994) Thyroid cancer in children and adolescents. Tumori 80: 257-262.
38. Segal K, Shvero J, Stern Y, Mechlis S, Feinmesser R (1998) Surgery of thyroid cancer in children and adolescents. Head Neck 20: 293-297.
39. Dottorini ME, Vignati A, MAzzucchelli L, Lomuscio G, Colombo L (1997) Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. J Nucl Med 38: 669-675.
40. Hay ID, Gonzalez-Losada T, Reinalda MS, Honetschlager JA, Richards ML, Thompson GB (2010) Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg 34: 1192-1202.